低剖面胃造瘻管市場按產品、置入方法、材料、年齡層、應用、尺寸和最終用戶分類－全球預測，2026-2032年

2025 年低位胃造瘻管市場價值為 5.8524 億美元，預計到 2026 年將成長至 6.1246 億美元，預計到 2032 年將達到 8.4806 億美元，複合年成長率為 5.44%。

關鍵市場統計數據
基準年 2025	5.8524億美元
預計年份：2026年	6.1246億美元
預測年份 2032	8.4806億美元
複合年成長率 (%)	5.44%

全面審視影響低調胃造瘻管領域的臨床需求、營運促進因素和相關人員優先事項

低位胃造瘻管在現代經腸營養策略中發揮核心作用，它連接了醫院、診所和居家照護環境，其設計旨在實現持續通暢、提高患者舒適度並最大限度降低併發症風險。臨床醫師和採購負責人越來越重視那些易於插入、位置穩固、材料生物相容性好，且能夠實現從急性期到慢性期連續護理的設備特性。本文闡述了低位胃造瘻管在臨床工作流程中的地位，並重點介紹了影響產品選擇和應用的跨職能因素。

臨床、材料和護理服務的變革性變化正在重新定義經腸營養通路裝置的產品設計、推廣路徑和供應鏈優先事項。

近年來，臨床創新、不斷發展的醫療服務模式以及對以患者為中心的治療結果的日益重視，推動了低位胃造瘻管領域的變革性發展。微創留置技術和裝置固定機制的改進增強了醫護人員的信心，並使腸內營養管理得以在更廣泛的臨床環境中應用。同時，材料科學的進步使得聚氨酯和矽膠等新型材料具有更高的抗張強度和生物相容性，從而延長了使用壽命，並降低了刺激和感染風險。

由於 2025 年實施的累積關稅政策，供應鏈重組已經重塑了設備利害關係人的籌資策略、國內採購獎勵和總成本考量。

美國2025年實施的關稅調整的累積影響，為胃造瘻管價值鏈帶來了可衡量的限制和機會。關稅變化改變了依賴進口原料和零件的製造商的投入成本結構，促使他們重新評估籌資策略、實現供應商多元化並調整預購做法。為此，一些製造商加快了關鍵投入品的在地採購或重新談判供應合約以緩解利潤壓力，而另一些製造商則致力於產品重新設計，以減少對關稅敏感材料的依賴。

詳細的細分分析揭示了產品類型、臨床環境、留置技術、材料、患者人口統計特徵、應用、通路和尺寸如何驅動不同的需求模式

細緻的市場細分觀點揭示了需求促進因素和市場接受度因產品組合、終端用戶環境、留置技術、材料成分、患者年齡、臨床應用、通路和器械尺寸而異。球囊固定式和固定式器械之間的產品細分突顯了易於更換和長期穩定性之間的權衡，這會影響臨床醫生根據預期治療時間和手術環境做出的選擇。終端使用者包括門診中心、居家醫療、醫院（每家醫院又細分為不同的子類型，例如社區醫院和教學醫院）以及專科診所，每種環境對員工培訓、庫存水準和術後支援都有其獨特的要求。

區域趨勢正在影響美洲、歐洲、中東和非洲以及亞太地區的監管協調、報銷途徑、臨床醫生採納情況以及供應鏈策略。

區域趨勢對監管路徑、報銷框架、臨床實務規範和供應鏈結構有顯著影響，從而塑造出差異化的市場進入策略。在美洲，臨床應用趨勢與門診服務的擴展、支付主導的成本控制舉措以及對器械耐用性和上市後證據的高度重視密切相關，而這些因素正是報銷和採購決策的依據。服務該地區的製造商通常會優先考慮監管合規、建立全國經銷夥伴以及開展培訓項目，以促進從住院治療過渡到居家治療。

深入洞察競爭考察和營運模式的公司，重點關注臨床證據、設計創新和經銷夥伴，以推動差異化應用和商業性韌性。

醫療設備製造商、契約製造製造商、經銷商和服務供應商之間的競爭主要集中在以下幾個方面：提高藥物保留機制、材料科學和支援服務的創新，以實現更安全、更便捷的長期腸內營養途徑。那些優先考慮臨床證據產生、高效醫護人員培訓和上市後監測的公司，在確保產品列入醫院處方集和簽訂長期採購合約方面具有優勢。製造商與大型經銷商或集團採購組織之間的策略聯盟已成為加速市場滲透和實現醫療機構產品供應標準化的常見手段。

為製造商和相關人員制定可操作的策略重點，以透過創新和價值鏈整合來提升韌性、促進臨床應用並創造差異化價值。

產業領導者應優先考慮協作模式，將產品創新、供應鏈韌性和與醫療服務提供者的合作相結合，以推動產品普及並維持利潤率。投資材料研究，最佳化聚氨酯和矽膠配方，以提高其長期生物相容性並減少併發症，既能滿足醫療服務提供者和患者的需求，又能幫助企業在採購談判中脫穎而出。同時，加強與國內和區域供應商的關係可以降低關稅風險，提高對需求波動的應對力，並實現更可預測的前置作業時間和品管。

採用穩健的混合方法研究途徑，結合臨床文獻、相關人員訪談、設備規格和情境分析，以獲得可操作的見解。

本分析整合了官方監管指南、同行評審的臨床文獻、製造商技術規範、採購政策以及相關人員訪談，以全面了解低輪廓胃造瘻管。資料收集結合了來自臨床醫生、供應鏈專家和採購人員的定性資訊，以及對設備設計、材料和置入技術的技術評估。證據綜合強調了同儕審查的結果和上市後安全性報告，以支持商業性應用與臨床實際情況的結合。

總之，這項綜合分析強調了產品創新、臨床檢驗和供應鏈策略的整合，以促進經腸營養獲取的成果和推廣。

低調的胃造瘻管市場呈現出穩定的臨床需求、不斷演變的器材設計要求以及強調整合解決方案和供應鏈韌性的商業性趨勢。從急診醫院到居家醫療，相關人員都認同以下優先事項：簡化置入和維護、材料生物相容性以及可靠的售後支持，從而減少併發症和非計劃性治療。這些優先事項正在影響創新流程和採購標準，並促使製造商在產品性能、服務和培訓之間取得平衡。

目錄

第1章：序言

第2章調查方法

• 研究設計
• 研究框架
• 市場規模預測
• 數據三角測量
• 調查結果
• 調查前提
• 調查限制

第3章執行摘要

• 首席主管觀點
• 市場規模和成長趨勢
• 2025年市佔率分析
• FPNV定位矩陣，2025
• 新的商機
• 下一代經營模式
• 產業藍圖

第4章 市場概覽

• 產業生態系與價值鏈分析
• 波特五力分析
• PESTEL 分析
• 市場展望
• 上市策略

第5章 市場洞察

• 消費者洞察與終端用戶觀點
• 消費者體驗基準
• 機會地圖
• 分銷通路分析
• 價格趨勢分析
• 監理合規和標準框架
• ESG與永續性分析
• 中斷和風險情景
• 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 低剖面胃造瘻管市場（依產品分類）

• 球囊保留
• 固定保留

9. 低剖面胃造瘻管市場依安裝方式分類

• 內視鏡
• 放射學
• 外科

第10章 低剖面胃造瘻管市場（依材料分類）

• 聚氨酯
• 矽酮

第11章 低輪廓胃造瘻管市場依年齡層別分類

• 成人版
• 老年人
• 兒童

第12章 低剖面胃造瘻管市場依應用領域分類

• 癌症
• 神經系統疾病

13. 低剖面胃造瘻管市場（依尺寸分類）

• 12 Fr
• 14 Fr
• 16 Fr
• 18 Fr

第14章 低剖面胃造瘻管市場（依最終使用者分類）

• 門診治療中心
• 居家醫療
• 醫院
• 專科診所

15. 低剖面胃造瘻管市場（依地區分類）

• 美洲
  • 北美洲
  • 拉丁美洲
• 歐洲、中東和非洲
  • 歐洲
  • 中東
  • 非洲
• 亞太地區

第16章 低剖面胃造瘻管市場（依組別分類）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

17. 各國低剖面胃造瘻管市場

• 美國
• 加拿大
• 墨西哥
• 巴西
• 英國
• 德國
• 法國
• 俄羅斯
• 義大利
• 西班牙
• 中國
• 印度
• 日本
• 澳洲
• 韓國

第18章：美國低輪廓胃造瘻管市場

第19章 中國低剖面胃造瘻管市場

第20章 競爭格局

• 市場集中度分析，2025年
  • 濃度比（CR）
  • 赫芬達爾-赫希曼指數 (HHI)
• 近期趨勢及影響分析，2025 年
• 2025年產品系列分析
• 基準分析，2025 年
• Abbott Laboratories
• Amsino International, Inc.
• Applied Medical Technology, Inc.
• Avanos Medical, Inc.
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Cardinal Health, Inc.
• ConMed Corporation
• Cook Group, Inc.
• Danone SA
• Degania Silicone Ltd.
• Fresenius Kabi AG
• GBUK Group Limited
• Medinova Endosys Private Limited
• Medline Industries, Inc.
• Nestle Health Science SA
• Poly Medicure Limited
• Silmag Medical Devices Pvt. Ltd.
• Vesco Medical
• Vygon SA

The Low Profile Gastrostomy Tube Market was valued at USD 585.24 million in 2025 and is projected to grow to USD 612.46 million in 2026, with a CAGR of 5.44%, reaching USD 848.06 million by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 585.24 million
Estimated Year [2026]	USD 612.46 million
Forecast Year [2032]	USD 848.06 million
CAGR (%)	5.44%

Comprehensive introduction framing clinical necessity, operational drivers, and cross-stakeholder priorities shaping the low profile gastrostomy tube landscape

Low profile gastrostomy tubes occupy a central role in modern enteral feeding strategies, bridging hospital, clinic, and home care settings with devices engineered for sustained access, patient comfort, and minimized complication risk. Clinicians and procurement leaders increasingly prioritize device attributes that deliver ease of placement, secure retention, and material biocompatibility while enabling continuity of care across acute and chronic care pathways. This introduction situates low profile gastrostomy tubes within clinical workflows and highlights the cross-functional considerations that shape product selection and adoption.

The device's clinical significance is amplified by demographic shifts and evolving care models that emphasize outpatient management and home-based nutrition. As placement techniques advance and multidisciplinary care teams refine protocols, device performance requirements extend beyond immediate functionality to include long-term durability, infection control, and patient-centered features that support quality of life. Alongside clinical drivers, regulatory oversight and reimbursement frameworks continue to influence procurement decisions, underscoring the need for coordinated evidence generation and stakeholder education. This introduction frames the subsequent analysis by outlining the core clinical, operational, and commercial forces that define the landscape for low profile gastrostomy tubes.

Transformative clinical, material, and care delivery shifts that are redefining product design, adoption pathways, and supply chain priorities for enteral access devices

Recent years have produced transformative shifts across the low profile gastrostomy tube landscape driven by clinical innovation, evolving care delivery models, and heightened attention to patient-centered outcomes. Minimally invasive placement techniques and refinements in device retention mechanisms have expanded clinician confidence, enabling a broader set of care settings to manage enteral access. Concurrently, materials science advances have yielded polyurethane and silicone options with improved tensile strength and biocompatibility, supporting extended use while mitigating irritative and infection risks.

Care delivery has shifted toward ambulatory and home-based management, prompting manufacturers to prioritize ease of handling, simplified maintenance, and compatibility with telehealth-assisted training programs. Regulatory bodies and payer systems are aligning incentives to support reduced inpatient stays, which reinforces demand for devices optimized for outpatient use. In parallel, digital health integration and supply chain resilience have become defining priorities, with stakeholders seeking products that align with standardized inventory management, remote monitoring, and evidence-based protocols. These converging dynamics are reshaping product design, commercialization strategies, and the operational expectations of providers and caregivers.

Cumulative 2025 tariff-driven supply chain realignments that reshaped procurement strategies, domestic sourcing incentives, and total cost considerations for device stakeholders

The cumulative impact of United States tariff adjustments implemented in 2025 has introduced measurable constraints and opportunities across the gastrostomy tube value chain. Tariff changes altered input cost structures for manufacturers that rely on imported raw materials and subcomponents, prompting adjustments to procurement strategies, supplier diversification, and forward-buying practices. In response, some manufacturers accelerated localization of critical inputs or renegotiated supply contracts to mitigate margin pressure, while others pursued product redesign to reduce dependence on tariff-exposed materials.

For distributors and hospital purchasing teams, higher landed costs translated into tighter procurement negotiations and renewed emphasis on total cost of ownership versus unit price alone. This shift incentivized long-term contracts, group purchasing collaborations, and greater scrutiny of logistics and inventory carrying costs. Clinicians and health systems experienced indirect effects as formulary decisions and device selections increasingly considered durability and complication avoidance to offset higher replacement expenses. On the upside, tariff-driven supply chain recalibration stimulated investment in domestic manufacturing capacity and quality assurance processes, creating opportunities for near-shore partners and contract manufacturers positioned to meet regulatory compliance and speed-to-market expectations. Overall, the tariff environment in 2025 catalyzed strategic realignment across manufacturing, distribution, and procurement without fundamentally altering clinical performance requirements.

Granular segmentation analysis revealing how product types, clinical settings, placement techniques, materials, patient cohorts, applications, channels, and sizes drive divergent demand patterns

A nuanced segmentation lens reveals differentiated demand drivers and adoption vectors that vary by product configuration, end-user environment, placement technique, material composition, patient age, clinical application, distribution pathway, and device size. Product segmentation between balloon retention and fixed retention devices highlights trade-offs between ease of replacement and long-term stability, influencing clinician preference depending on anticipated duration of therapy and procedural setting. End users encompass ambulatory care centers, home healthcare, hospitals-each with distinct subprofiles such as community hospitals and teaching hospitals-and specialty clinics, and each setting imposes unique requirements for staff training, inventory depth, and post-placement support.

Placement method segmentation across endoscopic, radiologic, and surgical techniques underscores procedural workflow differences that affect device selection criteria, with endoscopic and radiologic approaches commonly favored for minimally invasive access while surgical methods remain relevant for complex anatomies. Material segmentation differentiates polyurethane and silicone, each offering specific flexibility, bioresistance, and tactile handling characteristics that influence clinician choice and patient comfort. Age group segmentation across adult, geriatric, and pediatric populations requires tailored size selection and care protocols to address anatomical and developmental considerations. Application segmentation for indications such as cancer and neurological disorders highlights diverse nutritional and care continuity needs, often necessitating interdisciplinary coordination. Distribution channel segmentation spans direct sales, distributors-including group purchasing organizations and medical device distributors-online retail, and retail pharmacies, shaping procurement cadence, negotiation leverage, and post-sale service models. Size segmentation across 12 Fr, 14 Fr, 16 Fr, and 18 Fr further aligns device selection to clinical requirements and feeding formulations. Synthesizing these intersecting segments enables a refined view of product development priorities, clinical education focus areas, and commercial strategies that must be calibrated to each segment's operational realities.

Region-specific dynamics shaping regulatory alignment, reimbursement pathways, clinician adoption, and supply chain strategies across Americas, EMEA, and Asia-Pacific

Regional dynamics exert a strong influence on regulatory pathways, reimbursement frameworks, clinical practice norms, and supply chain configurations, shaping differentiated strategies for market engagement. In the Americas, clinical adoption trends are closely tied to outpatient care expansion, payer-driven cost containment initiatives, and a strong emphasis on device durability and post-market evidence that supports reimbursement and procurement decisions. Manufacturers serving the region often prioritize regulatory alignment, domestic distribution partnerships, and training programs that facilitate transition from inpatient to home-based management.

In Europe, Middle East & Africa, variability in national regulations, procurement practices, and hospital purchasing models requires adaptable regulatory and commercial strategies. Adoption in this region is shaped by clinician networks, regional tenders, and the need for robust clinical data to support formulary inclusion across diverse health systems. Manufacturers and distributors frequently tailor product offerings and service bundles to meet specific national requirements and to address infrastructure heterogeneity. In the Asia-Pacific region, demographic trends, rapid expansion of healthcare infrastructure, and growing home healthcare capabilities create significant demand potential, but stakeholders must navigate local manufacturing expectations, cost sensitivity, and variable regulatory timelines. Across all regions, supply chain resilience, localized training, and evidence generation remain central to sustained adoption and market access.

Competitive and operational company insights emphasizing clinical evidence, design innovation, and distribution partnerships that drive differentiated adoption and commercial resilience

Competitive dynamics among device manufacturers, contract manufacturers, distributors, and service providers center on innovation in retention mechanisms, material science, and support services that enable safer, more convenient long-term enteral access. Companies that prioritize clinical evidence generation, streamlined clinician training, and post-market surveillance are better positioned to secure hospital formularies and long-term procurement agreements. Strategic alliances between manufacturers and large distributors or group purchasing organizations have become a common mechanism to accelerate market penetration and standardize product availability across care settings.

Operational excellence in manufacturing quality, regulatory compliance, and supply chain transparency differentiates market leaders from smaller entrants. Investment in human factors engineering and patient-centric design increases product stickiness among outpatient and home-care cohorts, while robust customer support and clinician education programs reduce complication rates and device churn. Several firms are expanding service capabilities, including equipment leasing models and bundled training, to create integrated value propositions. Firms that combine clinical credibility, scalable quality systems, and flexible commercial models will likely sustain competitive advantage as providers emphasize integrated solutions that reduce total cost and improve patient outcomes.

Actionable strategic priorities for manufacturers and stakeholders to drive resilience, clinical adoption, and differentiated value through innovation and supply chain alignment

Industry leaders should prioritize a coordinated approach that aligns product innovation, supply chain resilience, and clinician engagement to accelerate adoption and preserve margin integrity. Investing in materials research to optimize polyurethane and silicone formulations for long-term biocompatibility and reduced complication profiles will address clinician and patient priorities while supporting differentiation in procurement discussions. Concurrently, strengthening domestic and near-shore supplier relationships can mitigate exposure to tariff volatility and improve responsiveness to demand fluctuations, enabling more predictable lead times and quality control.

Commercial strategies should focus on tailored engagement by end-user segment; hospital systems, ambulatory centers, home healthcare providers, and specialty clinics each require distinct value propositions centered on training, service, and total cost implications. Prioritize partnerships with distributors and group purchasing organizations where scale advantages are critical, and develop digital tools and educational resources to support remote training and caregiver competency. Finally, adopt a data-centric posture by investing in post-market surveillance, real-world evidence collection, and outcomes measurement to substantiate clinical value, support reimbursement conversations, and guide continuous product improvement. This integrated strategy will enhance competitive positioning and align product portfolios with evolving care delivery models.

Robust mixed-methods research approach combining clinical literature, stakeholder interviews, device specifications, and scenario analysis to produce actionable insights

This analysis synthesized public regulatory guidance, peer-reviewed clinical literature, manufacturer technical specifications, procurement policies, and stakeholder interviews to assemble a comprehensive perspective on low profile gastrostomy tubes. Data collection combined qualitative inputs from clinicians, supply chain professionals, and procurement leaders with technical evaluations of device design, materials, and placement methodologies. Evidence synthesis emphasized peer-reviewed outcomes and post-market safety reports to ground commercial implications in clinical reality.

Analytical methods included cross-segmentation mapping to reconcile device attributes with end-user needs, region-specific regulatory review to identify access barriers, and scenario-based impact assessment for supply chain shocks such as tariff adjustments. Validation steps incorporated expert reviews and reconciliation of divergent stakeholder perspectives to ensure findings reflected operational constraints and adoption drivers. The methodology prioritized transparency in source attribution and applied conservative interpretation of secondary reports, focusing on reproducible insights that support strategic planning and operational decision-making.

Concluding synthesis emphasizing integration of product innovation, clinical validation, and supply chain strategy to advance enteral access outcomes and adoption

The low profile gastrostomy tube landscape is characterized by steady clinical demand, evolving device design imperatives, and shifting commercial dynamics that favor integrated solutions and supply chain resilience. Across settings from acute hospitals to home care, stakeholders are converging on priorities that include simplified placement and maintenance, material biocompatibility, and reliable post-market support that reduces complications and unplanned care. These priorities are shaping innovation pipelines and procurement criteria alike, encouraging manufacturers to balance product performance with service and training offerings.

Looking ahead, sustained emphasis on outpatient care delivery, clinician education, and evidence generation will determine which products achieve broad adoption and long-term formulary inclusion. Organizations that align clinical validation with operational reliability and commercially viable distribution strategies will be best able to meet provider needs and support patient-centered care pathways. The conclusion synthesizes these themes into a clear imperative: integrating product innovation, supply chain strategy, and clinical engagement is essential to advance enteral access care and to deliver measurable improvements in patient outcomes and system efficiency.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Low Profile Gastrostomy Tube Market, by Product

• 8.1. Balloon Retention
• 8.2. Fixed Retention

9. Low Profile Gastrostomy Tube Market, by Placement Method

• 9.1. Endoscopic
• 9.2. Radiologic
• 9.3. Surgical

10. Low Profile Gastrostomy Tube Market, by Material

• 10.1. Polyurethane
• 10.2. Silicone

11. Low Profile Gastrostomy Tube Market, by Age Group

• 11.1. Adult
• 11.2. Geriatric
• 11.3. Pediatric

12. Low Profile Gastrostomy Tube Market, by Application

• 12.1. Cancer
• 12.2. Neurological Disorders

13. Low Profile Gastrostomy Tube Market, by Size

• 13.1. 12 Fr
• 13.2. 14 Fr
• 13.3. 16 Fr
• 13.4. 18 Fr

14. Low Profile Gastrostomy Tube Market, by End User

• 14.1. Ambulatory Care Centers
• 14.2. Home Healthcare
• 14.3. Hospitals
• 14.4. Specialty Clinics

15. Low Profile Gastrostomy Tube Market, by Region

• 15.1. Americas
  • 15.1.1. North America
  • 15.1.2. Latin America
• 15.2. Europe, Middle East & Africa
  • 15.2.1. Europe
  • 15.2.2. Middle East
  • 15.2.3. Africa
• 15.3. Asia-Pacific

16. Low Profile Gastrostomy Tube Market, by Group

• 16.1. ASEAN
• 16.2. GCC
• 16.3. European Union
• 16.4. BRICS
• 16.5. G7
• 16.6. NATO

17. Low Profile Gastrostomy Tube Market, by Country

• 17.1. United States
• 17.2. Canada
• 17.3. Mexico
• 17.4. Brazil
• 17.5. United Kingdom
• 17.6. Germany
• 17.7. France
• 17.8. Russia
• 17.9. Italy
• 17.10. Spain
• 17.11. China
• 17.12. India
• 17.13. Japan
• 17.14. Australia
• 17.15. South Korea

18. United States Low Profile Gastrostomy Tube Market

19. China Low Profile Gastrostomy Tube Market

20. Competitive Landscape

• 20.1. Market Concentration Analysis, 2025
  • 20.1.1. Concentration Ratio (CR)
  • 20.1.2. Herfindahl Hirschman Index (HHI)
• 20.2. Recent Developments & Impact Analysis, 2025
• 20.3. Product Portfolio Analysis, 2025
• 20.4. Benchmarking Analysis, 2025
• 20.5. Abbott Laboratories
• 20.6. Amsino International, Inc.
• 20.7. Applied Medical Technology, Inc.
• 20.8. Avanos Medical, Inc.
• 20.9. B. Braun Melsungen AG
• 20.10. Boston Scientific Corporation
• 20.11. Cardinal Health, Inc.
• 20.12. ConMed Corporation
• 20.13. Cook Group, Inc.
• 20.14. Danone S.A.
• 20.15. Degania Silicone Ltd.
• 20.16. Fresenius Kabi AG
• 20.17. GBUK Group Limited
• 20.18. Medinova Endosys Private Limited
• 20.19. Medline Industries, Inc.
• 20.20. Nestle Health Science S.A.
• 20.21. Poly Medicure Limited
• 20.22. Silmag Medical Devices Pvt. Ltd.
• 20.23. Vesco Medical
• 20.24. Vygon S.A.

LIST OF FIGURES

• FIGURE 1. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 13. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 14. UNITED STATES LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 15. CHINA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY BALLOON RETENTION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY BALLOON RETENTION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY BALLOON RETENTION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY FIXED RETENTION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY FIXED RETENTION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY FIXED RETENTION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY RADIOLOGIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY RADIOLOGIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY RADIOLOGIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SURGICAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY CANCER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY CANCER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 12 FR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 12 FR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 12 FR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 14 FR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 14 FR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 14 FR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 16 FR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 16 FR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 52. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 16 FR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 53. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 18 FR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 54. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 18 FR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 55. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 18 FR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 56. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 57. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 58. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 59. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 60. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 61. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 62. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 63. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 64. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 65. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 66. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 67. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 68. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 69. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 70. AMERICAS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 71. AMERICAS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 72. AMERICAS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 73. AMERICAS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 74. AMERICAS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 75. AMERICAS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 76. AMERICAS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 77. AMERICAS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 78. NORTH AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 79. NORTH AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 80. NORTH AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 81. NORTH AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 82. NORTH AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 83. NORTH AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 84. NORTH AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 85. NORTH AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 86. LATIN AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 87. LATIN AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 88. LATIN AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 89. LATIN AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 90. LATIN AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 91. LATIN AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 92. LATIN AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 93. LATIN AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 94. EUROPE, MIDDLE EAST & AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 95. EUROPE, MIDDLE EAST & AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 96. EUROPE, MIDDLE EAST & AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 97. EUROPE, MIDDLE EAST & AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 98. EUROPE, MIDDLE EAST & AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 102. EUROPE LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 103. EUROPE LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 104. EUROPE LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 105. EUROPE LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 106. EUROPE LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 107. EUROPE LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 108. EUROPE LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 109. EUROPE LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 110. MIDDLE EAST LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 111. MIDDLE EAST LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 112. MIDDLE EAST LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 113. MIDDLE EAST LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 114. MIDDLE EAST LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 115. MIDDLE EAST LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 116. MIDDLE EAST LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 117. MIDDLE EAST LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 118. AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 119. AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 120. AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 121. AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 122. AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 123. AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 124. AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 125. AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 126. ASIA-PACIFIC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 127. ASIA-PACIFIC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 128. ASIA-PACIFIC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 129. ASIA-PACIFIC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 130. ASIA-PACIFIC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 131. ASIA-PACIFIC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 132. ASIA-PACIFIC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 133. ASIA-PACIFIC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 134. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 135. ASEAN LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 136. ASEAN LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 137. ASEAN LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 138. ASEAN LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 139. ASEAN LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 140. ASEAN LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 141. ASEAN LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 142. ASEAN LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 143. GCC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 144. GCC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 145. GCC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 146. GCC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 147. GCC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 148. GCC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 149. GCC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 150. GCC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 151. EUROPEAN UNION LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 152. EUROPEAN UNION LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 153. EUROPEAN UNION LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 154. EUROPEAN UNION LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 155. EUROPEAN UNION LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 156. EUROPEAN UNION LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 157. EUROPEAN UNION LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 158. EUROPEAN UNION LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 159. BRICS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 160. BRICS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 161. BRICS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 162. BRICS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 163. BRICS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 164. BRICS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 165. BRICS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 166. BRICS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 167. G7 LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 168. G7 LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 169. G7 LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 170. G7 LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 171. G7 LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 172. G7 LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 173. G7 LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 174. G7 LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 175. NATO LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 176. NATO LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 177. NATO LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 178. NATO LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 179. NATO LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 180. NATO LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 181. NATO LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 182. NATO LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 183. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 184. UNITED STATES LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 185. UNITED STATES LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 186. UNITED STATES LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 187. UNITED STATES LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 188. UNITED STATES LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 189. UNITED STATES LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 190. UNITED STATES LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 191. UNITED STATES LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 192. CHINA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 193. CHINA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 194. CHINA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 195. CHINA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 196. CHINA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 197. CHINA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 198. CHINA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 199. CHINA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)